Position in ENTA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,786,366
+$742,942 QoQ
Shares Held
259,696
+7.8% QoQ
Ownership
0.892%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ENTA ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,786,366 | 259,696 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,043,424 | 240,968 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,625,348 | 229,889 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,344,874 | 195,896 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,899,175 | 251,214 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,769,224 | 320,512 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,227,411 | 387,376 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $5,560,262 | 536,705 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,961,153 | 845,116 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,296,394 | 933,356 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,802,987 | 935,493 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $10,722,148 | 959,906 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,860,226 | 974,777 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $34,912,497 | 863,316 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,083,206 | 883,130 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $50,023,789 | 964,407 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,022,124 | 931,291 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $66,061,657 | 928,093 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $75,689,622 | 1,012,164 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $54,483,514 | 959,048 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,553,773 | 648,802 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $31,807,156 | 644,914 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,008,389 | 237,729 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,355,315 | 248,041 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,786,477 | 254,660 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $13,298,047 | 258,566 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||